Researchers in California have revealed how often cancers return and spread in the body among young cancer patients.

DelveInsight's Rhabdomyosarcoma Market Insights report includes a comprehensive understanding of current treatment practices, ...

When is the Blight Survival release date? In this medieval adventure, you play a knight who fights against the forces of a rival kingdom and the bloodthirsty, infected monsters that plague the land in ...

First-line use of encorafenib and binimetinib in BRAF V600E NSCLC recorded a median overall survival of 47.6 months, according to data presented at the ESMO congress.

Leading Hunter artists are joining forces at Timeless Textiles Gallery on Sunday to raise urgently needed funds for a young man fighting stage four cancer.